1 Our previous results showed that the non-selective nitric oxide synthase (NOS) inhibitor L-N G -nitroarginine (L-NOARG) and the selective inducible NOS (iNOS) inhibitor N-(3-(acetaminomethyl)-benzyl)acetamidine (1400W) inhibited the relaxant eect of vasoactive intestinal polypeptide (VIP) in isolated smooth muscle cells of the mouse gastric fundus, suggesting the involvement of iNOS. The identity of the NOS isoform involved in the VIP-induced relaxation in isolated smooth muscle cells of the mouse gastric fundus was now further investigated by use of antisense oligodeoxynucleotides (aODNs) to iNOS. 2 Incubation of isolated smooth muscle cells with¯uorescein isothiocyanate (FITC)-labelled aODNs showed that nuclear accumulation occurs quickly and reaches saturation after 60 min. The in vivo intravenous administration of aODNs to iNOS, 24 and 12 h before murine tumour necrosis factor alpha (mTNFa) challenge, signi®cantly reduced the nitrite levels induced by the mTNFa challenge. 3 Intravenous administration of aODNs to iNOS in mice, 24 and 12 h before isolation of the gastric smooth muscle cells, decreased the inhibitory eect of the NOS inhibitors L-NOARG and 1400W on the relaxant eect of VIP, whereas neither saline nor sODNs had any in¯uence. 4 Preincubation of the isolated smooth muscle cells with aODNs almost abolished the inhibitory eect of L-NOARG and 1400W on the VIP-induced relaxation, whereas sODNs failed. 5 These results illustrate that the inhibitory eect of NOS inhibitors in isolated smooth muscle cells of the mouse gastric fundus is due to inactivation of iNOS. iNOS, probably induced by the isolation procedure of the smooth muscle cells, seems involved in the relaxant eect of VIP in isolated gastric smooth muscle cells.
Introduction
Several lines of evidence favour an important role for nitric oxide (NO) and vasoactive intestinal polypeptide (VIP) as inhibitory non adrenergic non cholinergic neurotransmitters in the regulation of gastrointestinal motility (Brookes, 1993; Lefebvre, 1993; Shuttleworth & Keef, 1995) . However, the mode of interaction between NO and VIP remains controversial. Most investigators believe that NO and VIP are released in parallel. Indeed, immuno¯uorescence studies revealed colocalization of VIP and neuronal NO synthase (nNOS) in many neurons of the myenteric plexus from dierent gastrointestinal tissues (see e.g. Lefebvre et al., 1995) . NO, which is generated from L-arginine by the action of NO synthases, activates hereby soluble guanylyl cyclase and induces smooth muscle relaxation via elevation of guanosine 3'5' cyclic monophosphate (cyclic GMP; Moncada et al., 1991) . VIP acts via activation of the adenylyl cyclase/ adenosine 3'5' cyclic monophosphate (cyclic AMP) signal transduction pathway (Bitar & Makhlouf, 1982b) . The notion of this parallel mode of action between NO and VIP is supported by the observation that the relaxation by VIP is not blocked by NOS inhibitors in smooth muscle strips from dierent gastrointestinal tissues such as the opossum lower esophageal sphincter (Tùttrup et al., 1991) , rat gastric fundus (Boeckxstaens et al., 1992) , cat gastric fundus (Barbier & Lefebvre, 1993) , pig gastric fundus (Lefebvre et al., 1995) and human gastric fundus (Tonini et al., 2000) .
In contrast, Makhlouf and colleagues propose a sequential model, whereby VIP is the predominant enteric inhibitory neurotransmitter and NO is largely produced in postjunctional muscle cells in response to VIP stimulation (Grider et al., 1992; Grider, 1993; Jin et al., 1993) . Indeed, studies in isolated smooth muscle strips and smooth muscle cells of the guinea-pig gastric fundus and rat colon, demonstrated that NOS inhibitors were able to inhibit the relaxant eect of exogenous VIP, and that VIP induced NO release as assessed by measuring 3 H-L-citrulline after loading the strips or cells with 3 H-L-arginine. Teng et al. (1998) reported, having used reverse transcription-polymerase chain reaction and Southern Blot Analysis, that eNOS would be responsible for the muscular production of NO in response to VIP in rabbit gastric and human intestinal smooth muscle cells, although Western and immunoblot analysis of these tissues did not reveal the presence of eNOS. Correspondingly, BoÈ rjesson et al. (1999) reported that the relaxant eect of VIP in segments of the rat distal colon was partially reduced by both the protein kinase A inhibitor H-89 and the guanylate cyclase inhibitor ODQ. Still, careful analysis of a possible sequential link between VIP and NO in canine gastric fundus and colon was negative (Keef et al., 1994; Bayguinov et al., 1999) .
Recent results obtained in our laboratory in the guinea-pig, pig and mouse gastric fundus demonstrate a clearcut discrepancy in the mechanism of VIP when studied in isolated smooth muscle cells versus smooth muscle strips. In the smooth muscle strips, the relaxation by exogenous VIP was not in¯uenced by NOS inhibitors, but in isolated smooth muscle cells it clearly was Dick et al., submitted) . The active NOS inhibitors included the selective inducible NO synthase (iNOS) inhibitor 1400W, which suggests that an NOS with properties of iNOS is involved in the relaxation induced by VIP in the isolated smooth muscle cells. Further evidence for iNOS involvement was obtained by use of iNOS and eNOS knockout mice. The inhibitory eect of the NOS inhibitors was still present in isolated smooth muscle cells from eNOS knockout mice but not in isolated smooth muscle cells from iNOS knockout mice, suggesting the involvement of iNOS, and not eNOS, in the relaxation by VIP in isolated smooth muscle cells (Dick et al., submitted) . All these results thus suggest that the isolation procedure of isolated smooth muscle cells leads to the induction of iNOS that can be activated by VIP.
Antisense oligodeoxynucleotides (aODNs) are short nucleic acid fragments, generally 15 ± 25 bases in length, designed to interfere with gene function through the hybridization with their speci®c mRNAs (Crooke, 1992 (Crooke, , 1995 Stein & Cheng, 1993) . Knockdown strategy with aODNs oers the opportunity to block the gene of interest with high selectivity. The aim of the present study was therefore to further investigate the identity of the NO synthase involved in the VIP-induced relaxation in isolated smooth muscle cells of the mouse gastric fundus by use of aODNs to iNOS.
Methods

Animals
Eight to ten week old C57BL/J6 mice from either sex (25 ± 30 g) were purchased from Ia Credo (les Oncins, France) and housed in a 12 h light/dark cycle in a temperaturecontrolled, air conditioned room with food and water ad libitum.
Antisense oligonucleotides
The 18-base phosphorothioated antisense oligodeoxynucleotides (aODNs) 5'-CACCTCCAACACAAGATC-3', complementary to the bases 1 through 18 of the mouse iNOS cDNA sequence (Genbank accession number M87039) were purchased from Biognostik (GoÈ ttingen, Germany). The corresponding sense ODNs (sODNs) sequence with the base composition 5'-CCTTCGTACCCTTTTTCC-3', was used as control ODNs.
In vivo administration of ODNs
Mice were randomly divided into three groups receiving 2 nmol aODNs, 2 nmol sODNs or 200 ml saline intravenously (i.v.) 24 and 12 h before the isolation procedure of the gastric smooth muscle cells. The aODNs and sODNs were dissolved in a total volume of 200 ml saline and injected with a 26 gauge needle in the vein of the mouse tail, warmed up under infrared light for a few minutes. The project was approved by the Ethics Committee for Experimental Animals of the Faculty of Medecine and Health Sciences, Ghent University.
In vitro administration of ODNs
After enzymatic dissociation of the smooth muscle cells (see below), 4 nmol aODNs or 4 nmol sODNs both dissolved in 40 ml saline were added to the enzyme-free medium (®nal concentration 1 nmol ml
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) in which the cells are allowed to disperse spontaneously for 60 min.
In vitro cellular uptake study with FITC-labelled aODNs Once the smooth muscle cells were completely dissociated, uorescein isothiocyanate (FITC)-labelled aODNs were added to the medium. Samples of these cells were viewed after an interval of 0, 7.5, 22.5, 37.5, 52.5 and 67.5 min with an inverted Nikon Eclipse TE300 epi¯uorescence microscope using a 406oil-immersion lens. FITC¯uorescence images were obtained by excitation at 480 nm, re¯ection o a dichroic mirror with a cut-o wavelength at 510 nm, and bandpass emission ®ltering at 535 nm. Images were captured with an intensi®ed CCD (Extended Isis camera, Photonic Science, East Sussex, U.K.) and were stored in a PC equipped with an image acquisition and processing board (Data Translation, type DT3155, Marlboro, MA, U.S.A.). Nuclei were counterstained with 4',6-diamino-2-phenylindole (DAPI), 0.5 mg ml 71 in 0.01 M PBS for 1 min. The intensity of the highest signal obtained in the nucleus of the ®rst 8 ± 10 randomly encountered and morphologically intact cells was measured.
Evaluation of the iNOS aODNs efficiency in vivo by nitrite assay
To evaluate the ecacy of the aODNs to block the expression of iNOS, mice received 24 and 12 h before a challenge with mTNFa randomly 200 ml saline, 2 nmol aODNs or 2 nmol sODNs i.v. NOS activity in response to mTNFa was assessed by measurement of nitrite/nitrate production using the Griess reaction. Blood samples from the saline-, sODNs-or aODNs-treated mice challenged i.v. with 20 mg mTNFa were collected from the retro-orbital plexus under ether anaesthesia 3, 6 and 9 h after mTNFa challenge. The NO x 7 level in serum was determined by measuring the levels of nitrite and nitrate, following the procedure of Granger et al. (1991) in a slightly modi®ed form. Thirty microliters of nitrite and nitrate standards, prepared in pooled normal murine serum, or of samples was transferred to a V-or U-shaped microtiter plate. Pseudomonas oleovorans bacteria were quickly thawed and diluted in TC-100 medium to a concentration of 5610 9 Colony Forming Units (CFU) ml
71
. Thirty microliters of this bacterial suspension was then added to the samples and to the nitrate standard, which were incubated for at least 2 h at 378C. Thirty microliters of TC100 medium was added to the nitrite standard. Then the plate was centrifuged at 13006g for 5 min to remove the bacterial pellet. Forty microliters of supernatant was transferred to a second V-or U-shaped 96-well microtiter plate to which 80 ml of Griess reagent was added (Griess, 1879) . After thorough mixing, 80 ml of 10% Trichloroacetic Acid (TCA) was added to every well, and the plate was centrifuged at 13006g for 15 min to remove the protein precipitate. Finally, 120 ml of supernatant was transferred to a¯at-bottom 96-well microtiter plate; absorbance was determined at 540 (test) and 620 nm (ref).
Preparation of isolated smooth muscle cells
Circular smooth muscle cells were isolated from the gastric fundus of mice by collagenase digestion as previously described (Bitar & Makhlouf, 1982a; Botella et al., 1994) . Brie¯y, 3 ± 4 mice of either sex (25 ± 30 g) were killed by cervical dislocation. The gastric fundus was isolated immediately and the circular muscle layer was separated from the rest of the stomach wall by careful dissection under the microscope. Small sheets from the circular muscle layer were incubated for 15 min at 318C, in 15 ml of N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid (HEPES)-buered medium (25 mM), containing 150 U ml 71 collagenase (Type II) and 0.01% soybean trypsin inhibitor and gassed with a mixture of 95% O 2 and 5% CO 2 . The medium consisted of (mM): NaCl 98, KCl 6, NaH 2 PO 4 2.5, CaCl 2 1.8, D(+)-glucose 11.5, bovine serum albumin 0.2% (w v
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) and was supplemented with (mM): sodium pyruvate 5, sodium fumarate 5, sodium glutamate 5, glutamin 2, amino acid mixture, 1% (v v 71 ); vitamin mixture, 1% (v v 71 ); penicillin G, 50 mg ml 71 and streptomycin, 50 mg ml
. The pH of the buered medium was adjusted to 7.4. At the end of the incubation, the medium was ®ltered through a 500-mm Nitex ®lter and the partly digested tissues were washed with 30 ml enzyme-free medium, whereafter they were allowed to disperse spontaneously in enzyme free medium for 60 min. Finally the spontaneously dissociated muscle cells were harvested by ®ltration and used for functional measurements.
Viability tests by exclusion of Trypan blue (Collins & Gardner, 1982) showed that 86.6+1.2% (mean+s.e.mean, n=6) of the cells in suspension obtained from control mice were viable at the time of contraction experiments. Cell suspensions were studied usually within 30 min at 318C. The length of the isolated smooth muscle cells was determined by Image Splitting after ®xation with glutaraldehyde. An aliquot of 50 ml treated cell suspension was placed on a Malassez slide. The ®rst 25 or 50 randomly encountered and morphologically intact cells were measured using a Carl Zeiss eyepiece at a magni®cation of at least 200 times. For the vials with control cells and carbachol-treated cells, two dierent aliquots were taken and two times 25 or 50 cells were measured. The averaged value accounted for n=1 from one animal. The absolute cell length measurement was performed with a scale mask placed on a video screen, connected to a video camera. Magni®cation due to the video camera had been ®rst calculated by use of a micrometer.
Measurement of relaxation (inhibition of contraction) in isolated smooth muscle cells
Untreated cells served as controls. Cells were contracted by incubation with 10 nM carbachol for 30 s, followed by ®xation of the cells with glutaraldehyde (pH 7.4) to a ®nal concentration of 2.5%. In relaxation experiments, the relaxant agent VIP (1 nM) or pinacidil (10 mM) was added 60 s before carbachol. The inhibition of the carbacholinduced contraction was considered as relaxation as previously described (Grider et al., 1992; Jin et al., 1993; Rekik et al., 1996) . The term relaxation will be used throughout the study. To study the mechanism of relaxation, the cells were incubated before addition of relaxant agents with the NOS inhibitors L-N G -nitroarginine (L-NOARG, 100 mM; incubation time 5 min) and N-(3-(aminomethyl)-benzyl)acetamidine (1400W, 1 mM, 5 min), with or without L-arginine (100 mM, 5 min) or D-arginine (100 mM, 5 min) and glibenclamide (100 mM, 5 min). In parallel control vials, the cells were incubated with the solvent of these agents. The in¯uence of pinacidil, that relaxes smooth muscle by opening of ATP-sensitive K + -channels (Richer et al., 1990) , and the blocker of ATP-sensitive K + -channels glibenclamide (Schmid-Antomarchi et al., 1987) was studied to evaluate possible non-speci®c eects of the treatment with aODNs on relaxant agents and their antagonists.
Data analysis
The measured¯uorescence intensity of the cells was expressed as the percentage of the highest¯uorescence intensity obtained among all the viewed cells taken as 100%. The contraction of the isolated smooth muscle cells was expressed as the percentage decrease in cell length from untreated controls, using the following formula:
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)6100 where L 0 is the mean length of cells in control state and L x the mean length of carbachol-treated cells. In relaxation experiments, the degree of inhibition of contraction was expressed as the percentage decrease in maximal contractile response, as observed in carbachol-treated cells in the absence of relaxant agent.
Results are given as means+s.e.mean and n refers to material from dierent animals. Responses in parallel vials with isolated smooth muscle cells and nitrite levels from mice treated with aODNs versus those from mice treated with saline or sODNs were compared by analysis of variance (ANOVA) and the t-test corrected for multiple comparisons (Bonferroni procedure). The level of signi®cance was set at P50.05. All drugs were dissolved in deionized water, except for pinacidil which was dissolved in pure ethanol and glibenclamide in DMSO (dimethylsulphoxide). Further dilutions were made in physiological salt solution. The solvents, diluted in physiological salt solution until the ®nal concentration given to the cells had no eect per se on control isolated smooth muscle cells. For dissolving L-NOARG, powerful vortexing during at least 5 min was required. Stock solutions of 1400W up to 10 mM and VIP up to 100 mM were prepared in deionized water and stored at 7208C. ODNs were dissolved up to 1 nmol 10 ml 71 in saline and stored at 7208C. All other solutions were prepared on the day of the experiment.
Chemicals
Results
Control experiments
In vitro uptake study with FITC-labelled aODNs To investigate the intracellular incorporation of ODNs, isolated smooth muscle cells were exposed to¯uorescein isothiocyanate (FITC)-labelled aODNs and the¯uorescence intensity after 0, 7.5, 22.5, 37.5, 52.5, 67.5 min was measured. The nuclei of the circular smooth muscle cells, as con®rmed by counterstaining with DAPI, became brightly¯uorescent. The nuclear signal was much more intense than the nearly homogeneous, cytoplasmatic¯uorescence. The cellular uptake of the FITC-labelled aODNs was visible from 7.5 min after the administration and reached a plateau after 60 min incubation time (Figure 1a) .
Ecacy of iNOS aODNs in vivo
The eects of in vivo administration of aODNs, targeted to iNOS mRNA, and the corresponding sODN were examined on mTNFa-induced NO production. A time dependent increase of the serum nitrite/ nitrate level was observed after i.v. challenge with mTNFa in mice treated with saline. When animals were treated in vivo with aODNs before mTNFa challenge, the nitrite/nitrate level was signi®cantly decreased at 6 and 9 h after mTNFa challenge, but this was not the case in animals treated with sODNs ( Figure 1b) .
Isolated smooth muscle cells
In vivo eect of aODNs Untreated control cells, obtained after dispersion of the circular muscle layer of the gastric fundus of mice treated with saline, had a mean cell length of 118.7+2.4 mm. Carbachol (10 nM), incubated for 30 s, Figure 1 (a) Nuclear¯uorescence intensity of isolated smooth muscle cells measured by epi¯uorescence microscopy at 0, 7.5, 22.5, 37.5, 52.5 and 67.5 min after addition of FITC labelled aODNs. Values are mean+s.e.mean from 8 ± 10 dierent cells. (b) Concentration of nitrite, after reduction of nitrate to nitrite, detected in serum of mice treated with saline, sODNs or aODNs, 3, 6 and 9 h after mTNFa challenge. Values are mean+s.e.mean from n=3 ± 6. *P50.05 signi®cantly dierent from mice treated with saline, +P50.05 signi®cantly dierent from mice treated with sODNs.
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NO-VIP interaction J.M.C. Dick et alproduced 23.1+0.9% shortening of the cells to 91.4+2.7 mm. When cells were preincubated for 60 s with 1 nM VIP, the contraction was inhibited and full relaxation was obtained (Table 1) . The values for the cell length, the per cent contraction by carbachol and the per cent relaxation by VIP in smooth muscle cells obtained from mice treated with aODNs or sODNs were not signi®cantly dierent from those in cells of saline-treated animals (data not shown).
The relaxant eect of VIP in gastric smooth muscle cells obtained from saline-and sODNs-treated animals was inhibited by the non selective NOS inhibitor L-NOARG by 79.7+10.9%, respectively 74.2+16.1% (Figure 2) . The inhibitory eect of L-NOARG was reversed by 100 mM Larginine, but not by 100 mM D-arginine. When the cells obtained from saline and sODNs-treated animals were incubated with the iNOS selective inhibitor 1400W, the relaxant eect of VIP was inhibited by 80.5+9.4%, respectively 77.5+11.4% (Figure 2) . The inhibitory eect of 1400W on VIP-induced relaxation was not reversed by Larginine. In gastric smooth muscle cells of the mice treated with aODNs, the relaxant eect of VIP seemed partially inhibited by L-NOARG (49.1+11.0%) and by 1400W (38.5+11.0%) but this eect was not signi®cant (Figure 2) . None of the NOS inhibitors altered per se the mean cell length of the circular smooth muscle cells obtained from saline-, sODNs-or aODNs-treated animals, nor the degree of the carbachol-induced contraction (n=4; data not shown).
In vitro eect of aODNs Incubation of the partially digested tissues with sODNs or aODNs revealed no dierence in cell length, per cent contraction by carbachol or per cent relaxation by VIP of the isolated smooth muscle cells in comparison to untreated isolated smooth muscle cells (data not shown). When untreated cells or cells treated with sODNs were incubated with 100 mM L-NOARG, the relaxant eect of VIP was signi®cantly inhibited to the same extent (Figure 3 ). This inhibitory eect of L-NOARG was reversed by 100 mM L-arginine, but not by 100 mM D-arginine (n=6; data not shown). Preincubation of the untreated cells or cells treated with sODNs with 1 mM 1400W signi®cantly decreased the relaxant eect of VIP (Figure 3 ). This inhibitory eect of 1400W on the VIP-induced relaxation was not reversed by 100 mM L-arginine (n=6; data not shown). Contrary to these results obtained in untreated cells and cells treated with sODNs, the relaxant eect of VIP in cells treated with aODNs was not signi®cantly inhibited by the NOS inhibitors L-NOARG and 1400W (Figure 3) .
The K + channel opener pinacidil elicited full relaxation in dispersed smooth muscle cells at a concentration of 10 mM.
Both in untreated cells and cells treated with aODNs, 100 mM glibenclamide signi®cantly inhibited the pinacidil-induced relaxation by 87.5+12.6%, respectively 98.4+1.3% ( Figure  3) . L-NOARG, 1400W and glibenclamide did not alter the mean cell length or the degree of the carbachol-induced contraction in dispersed circular smooth muscle cells (n=4; data not shown).
Discussion
Contrary to the hypothesis of Teng et al. (1998) that an eNOS is involved in the relaxant eect of VIP in gastric smooth muscle, our previous results suggested that iNOS, probably induced by the isolation procedure, is responsible for the relaxation by VIP in isolated smooth muscle cells of guinea-pig, pig and mouse gastric fundus Dick et al., submitted) . The aim of the present study was therefore to con®rm the identity of the NOS isoform involved in the relaxation induced by VIP in smooth muscle cells isolated from the mouse gastric fundus by use of aODNs to iNOS.
To evaluate uptake and distribution of the phosphorothioate ODNs in vitro, FITC-labelled aODNs were incubated with freshly isolated smooth muscle cells and the cellular penetration was visualized by¯uorescence microscopy. From the beginning of the incubation, FITC-labelled aODNs penetrated into the nuclei of the cells and penetration reached saturation after 67.5 min incubation. Most authors report that aODNs enter cells in culture via receptor mediated endocytosis or¯uid phase pinocytosis (Loke et al., 1989; Bennett et al., 1993) and, in some cases, might become sequestered in intracellular compartments such as lysosomes and endosomes and never gain access to target mRNA (Wagner, 1994) . With regard to facilitating the penetration of the ODNs in vascular smooth muscle cell cultures, most authors add transfection reagent to the medium (Itoh et al., 1993; Busuttil et al., 1996; Marrero et al., 1998) . However, it is known that cell permeabilization and intracellular delivery of oligonucleotides facilitates the uptake of the aODNs into the nucleus (Wagner, 1994; Lesh et al., 1995) . Damage in¯icted to smooth muscle cells might allow more rapid uptake of aODNs and aect tissue and cellular distribution of oligonucleotides, as Farrell et al. (1995) demonstrated that oligonucleotides penetrate more easily into the arterial wall of balloon-injured arteries than in tissue from normal arteries. In our study, enzymatic digestion with collagenase could permeabilize the cell membrane, which Values are mean+s.e.mean from n=6; ***P50.001, signi®cantly dierent from control cells.
British Journal of Pharmacology vol 134 (2) NO-VIP interaction J.M.C. Dick et alallows facilitated uptake of the aODNs in the isolated smooth muscle cells in vitro, no transfection reagent seemed required. Our observation regarding nuclear accumulation of aODNs in the smooth muscle cells is signi®cant in that, at least in in vitro systems, nuclear accumulation generally correlates with positive antisense oligonucleotide activity (Bennett et al., 1992) .
The ecacy of in vivo administration of aODNs to iNOS mRNA has been reported. Hoque et al. (1998) indeed demonstrated the ability of i.v. administration of aODNs to iNOS mRNA to signi®cantly inhibit the LPS-induced increase in NOS activity and iNOS protein expression in rat. To evaluate in vivo the ecacy of the aODNs to block the expression of iNOS in mice challenged with mTNFa in our study, nitrite levels were measured in the serum of mice treated with aODNs, sODNs or saline. The aODNs treatment signi®cantly reduced the nitrite/nitrate levels in serum compared with control groups. This was not mimicked by sODNs showing that i.v. administration of aODNs to iNOS mRNA inhibits iNOS expression in mice by an antisense mechanism of action.
To identify the NOS isoform involved in the relaxant eect of VIP, the eect of the non-selective NOS inhibitor L-NOARG and the selective iNOS inhibitor 1400W was investigated on the relaxation by VIP in isolated smooth muscle cells obtained from mice treated intravenously with aODNs, sODNs or saline. As it was already observed in the guinea-pig, the pig and the mouse gastric fundus (Dick et al., Dick et al., submitted) . This might be related to the very tight binding of 1400W to iNOS (Garvey et al., 1997) . L-NOARG and 1400W did not signi®cantly reduce the VIP-induced relaxation in cells obtained from mice treated with aODNs. The eects of the aODNs was sequence speci®c, as sODNs failed to reduce the inhibitory eect of the NOS inhibitors on the relaxant eect of VIP. To con®rm our results obtained in vivo, we also studied the in¯uence of in vitro administration of the aODNs. Incubation of the cells with aODNs, almost abolished the eect of the NOS inhibitors on the VIP-induced relaxation, but this eect could not be perceived in untreated cells or cells incubated with sODNs. Glibenclamide is known to inhibit the relaxant eect of the potassium channel opener pinacidil in the rat gastric fundus (Lefebvre & Horacek, 1992) . In both untreated cells and cells incubated with aODNs, glibenclamide blocked the relaxation by pinacidil, con®rming the speci®city of the non-eect of NOS inhibitors on the relaxant eect of VIP in cells incubated with aODNs. The decreased inhibitory eect of L-NOARG and 1400W on the relaxation by VIP in smooth muscle cells, both after in vivo and in vitro treatment with aODNs to iNOS mRNA, corroborates that iNOS is involved in the relaxation by VIP in isolated smooth muscle cells.
The in¯uence of the aODNs on the inhibitory eect of the NOS inhibitors versus the VIP-induced relaxation tended to be more pronounced in the in vitro study compared to the in vivo study, although this did not reach statistical signi®cance. Oligonucleotide uptake and distribution in isolated smooth muscle cells in vitro are quite dierent from uptake into cells in vivo. Patterns of oligonucleotide distribution to the target tissues in vivo might contribute to this dierence, as the majority is distributed to the kidney and liver before becoming available to other tissues (Agrawal et al., 1991; Cossum et al., 1993) . Degradation in serum seems unlikely as the phosphorothioated aODNs used in this study have a sulphur atom replacing one of the non bridging oxygen atoms at each interbase phosphorus, creating a phosphorothioate linkage that is nuclease resistant (Tsuneyoshi et al., 1996) .
As discussed before , the involvement of iNOS in the relaxant eect of VIP in the isolated gastric smooth muscle cells might be related to the induction of iNOS in response to the stress of the dissociation procedure. Induction of iNOS can indeed also result from stress in response to ischaemia-reperfusion (Iadecola et al., 1996; Imagawa et al., 1999; Jones et al., 1999) . The whole procedure of cell dissociation takes about 2 h. This seems sucient for the expression of iNOS as Lui et al. (1997) demonstrated a threshold time point for iNOS mRNA induction between 20 and 40 min after lipopolysaccharide administration in rat vascular preparations, and iNOS activity was measurable in vascular endothelial cells activated with Interferon-g and LPS after a lag period of 2 h (Radomski et al., 1990) .
In vivo administration of aODNs or incubation of the isolated smooth muscle cells with aODNs in vitro did not aect the relaxant eect of VIP. Apparently, when the expression of the overwhelming iNOS-NO pathway is prevented, the classic mechanism of relaxation by VIP via cyclic AMP-protein kinase A remains active. Similar results were obtained in isolated smooth muscle cells of iNOS knockout mice where the relaxant eect of VIP was Figure 3 Eect of L-NOARG (100 mM) and 1400W (1 mM) on VIPinduced relaxation and of glibenclamide (GLIB; 100 mM) on pinacidil (PINA; 10 mM)-induced relaxation in mouse isolated gastric smooth muscle cells untreated (a), or treated with sODNs (b) or aODNs (c) in vitro. Values are mean+s.e.mean from n=4 ± 6. ***P50.001 signi®cantly dierent from cells treated with VIP, ++P50.01, +P50.05, signi®cantly dierent from cells treated with pinacidil. maintained but it was no longer in¯uenced by NOS inhibitors (Dick et al., submitted) .
In conclusion, in isolated gastric smooth muscle cells from mice treated with aODNs and in isolated smooth muscle cells incubated with aODNs, the inhibitory eect of the NOS inhibitors L-NOARG and 1400W versus the relaxant eect of VIP was signi®cantly decreased. These results illustrate that the inhibitory eect of the NOS inhibitors on the relaxant eect of VIP in isolated smooth muscle cells of the mouse gastric fundus is due to inactivation of iNOS. iNOS, probably induced by the isolation procedure of the gastric smooth muscle cells, seems involved in the relaxant eect of VIP in isolated gastric smooth muscle cells.
